Ticker League

EBITDA for HCA Healthcare (HCA)

Latest filings through · Reported

Metric

TTM

$15.67B

YoY change

+12.3%

5Y CAGR

+9.9%

Peak year (1998)

$18.68B

EBITDA history chart for HCA Healthcare (HCA) from 1990 to 2025

Latest: $15.60B

EBITDA growth chart for HCA Healthcare (HCA) from 1990 to 2025

Latest: +12.3%

EBITDA history table for HCA Healthcare (HCA) from 1990 to 2025

  • 2025$15.60B+12.3%
  • 2024$13.90B+9.2%
  • 2023$12.72B-4.3%
  • 2022$13.29B-6.7%
  • 2021$14.25B+46.4%
  • 2020$9.73B+0.7%
  • 2019$9.66B+3.2%
  • 2018$9.37B+14.2%
  • 2017$8.20B-3.3%
  • 2016$8.48B+12.7%
  • 2015$7.53B+6.8%
  • 2014$7.04B+7.6%
  • 2013$6.55B+2.8%
  • 2012$6.37B-9.8%
  • 2011$7.06B+22.9%
  • 2010$5.75B+6.2%
  • 2009$5.41B+17.5%
  • 2008$4.61B-4.6%
  • 2007$4.83B+20.5%
  • 2006$4.01B-4.1%
  • 2005$4.18B+10.4%
  • 2004$3.79B-6.3%
  • 2003$4.04B+31.2%
  • 2002$3.08B-6.4%
  • 2001$3.29B-81.3%
  • 2000$17.59B+0.3%
  • 1999$17.53B-6.2%
  • 1998$18.68B+555.2%
  • 1997$2.85B-29.4%
  • 1996$4.04B+11.6%
  • 1995$3.62B+71.0%
  • 1994$2.12B+6.8%
  • 1993$1.98B+2407.0%
  • 1992$79.10M+87.0%
  • 1991$42.30M+45.4%
  • 1990$29.10M—

EBITDA values are taken from HCA Healthcare's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at HCA Healthcare (HCA)

According to HCA Healthcare's latest reported financial statements, the company's current EBITDA (TTM) is $15.67B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

In 2025, HCA Healthcare (HCA) EBITDA totalled $15.60B – grew 12.3% year-over-year.

HCA Healthcare EBITDA compound annual growth for the 2020–2025 (5 years) window is +9.9%, sustaining 2 straight years of year-over-year growth.

Between 1998 and 2025, HCA Healthcare EBITDA declined 16.5%, falling from $18.68B to $15.60B.

$18.68B stands as the all-time-high annual EBITDA, posted in 1998, against a low of $29.10M during 1990.

HCA Healthcare EBITDA by Year

HCA Healthcare EBITDA 2025: $15.60B

In 2025, HCA Healthcare reported EBITDA of $15.60B, grew 12.3% from 2024.

HCA Healthcare EBITDA 2024: $13.90B

HCA Healthcare EBITDA in 2024 was $13.90B, grew 9.2% from 2023.

HCA Healthcare EBITDA 2023: $12.72B

2023's EBITDA for HCA Healthcare came in at $12.72B, edged down 4.3% below 2022.

HCA Healthcare EBITDA 2022: $13.29B

HCA Healthcare posted EBITDA of $13.29B in 2022, declined 6.7% below 2021.

HCA Healthcare EBITDA 2021: $14.25B

HCA Healthcare EBITDA in 2021 was $14.25B.

See more financial history for HCA Healthcare (HCA).

Sector peers by EBITDA

Healthcare peers of HCA Healthcare (HCA), ranked by their latest EBITDA

Frequently asked questions

HCA Healthcare (HCA) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview